Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
Holding BMRN?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 14, 2024 | Charles Greg Guyer Evp, Cto | xxxxxxxxxxxxx | $350301 |
| Mar 07, 2024 | Henry Fuchs President, Worldwide R&d | xxxxxxxxxxxxx | $3010346 |
| Mar 07, 2024 | Jean Jacques Bienaime Director | xxxxxxxxxxxxx | $172220 |
| Feb 29, 2024 | Jean Jacques Bienaime Director | xxxxxxxxxxxxx | $90350 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $318132 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $461453 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $650533 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $916441 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,867,435 | Institution | 9.90% | 1,212,421,373 | |
| 18,389,596 | Institution | 9.65% | 1,181,715,439 | |
| 16,788,800 | Institution | 8.81% | 1,078,848,288 | |
| 13,898,318 | Institution | 7.29% | 893,105,915 | |
| 13,209,176 | Institution | 6.93% | 848,821,650 | |
| 10,543,625 | Institution | 5.53% | 677,533,343 | |
| 9,753,293 | Institution | 5.12% | 626,746,608 | |
| 7,070,808 | Institution | 3.71% | 454,370,122 | |
| 5,486,780 | Institution | 2.88% | 352,580,483 | |
| 5,220,418 | Institution | 2.74% | 335,464,061 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,788,800 | Institution | 8.81% | 1,078,848,288 | |
| 10,543,625 | Institution | 5.53% | 677,533,343 | |
| 7,070,808 | Institution | 3.71% | 454,370,122 | |
| 5,486,780 | Institution | 2.88% | 352,580,483 | |
| 4,971,836 | Institution | 2.61% | 319,490,181 | |
| 4,610,520 | Institution | 2.42% | 296,272,015 | |
| 3,552,206 | Institution | 1.86% | 228,264,758 | |
| 1,973,809 | Institution | 1.04% | 126,836,966 | |
| 1,892,412 | Institution | 0.99% | 121,606,395 | |
| 750,307 | Institution | 0.39% | 48,214,728 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,016,631 | Institution | 3.16% | 396,435,817 | |
| 6,042,786 | Institution | 3.17% | 393,324,941 | |
| 4,039,354 | Institution | 2.12% | 266,153,035 | |
| 2,830,377 | Institution | 1.49% | 186,493,541 | |
| 2,422,185 | Institution | 1.27% | 159,597,770 | |
| 2,122,872 | Institution | 1.11% | 136,415,755 | |
| 1,531,667 | Institution | 0.80% | 99,696,205 | |
| 1,344,257 | Institution | 0.71% | 88,573,094 | |
| 1,299,535 | Institution | 0.68% | 84,586,733 | |
| 844,493 | Institution | 0.44% | 54,968,049 |
FAQ
Who Owns BioMarin Pharmaceutical (BMRN)?
Currently, no data Available
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors?
Currently, no data Available
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of BioMarin Pharmaceutical (BMRN)?
Theofanis Kolokotrones owns the most shares of BioMarin Pharmaceutical (BMRN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.